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Abstract
Background: Congenital cytomegalovirus (CMV) is the leading infectious cause of birth defects in the United States.
To better understand factors that may influence CMV transmission risk, we compared viral and immunological factors
in healthy children and their mothers.
Methods: We screened for CMV IgG antibodies in a convenience sample of 161 children aged 0–47 months from the
Atlanta, Georgia metropolitan area, along with 32 mothers of children who screened CMV-seropositive. We assessed
CMV shedding via PCR using saliva collected with oral swabs (children and mothers) and urine collected from diapers
using filter paper inserts (children only).
Results: CMV IgG was present in 31% (50/161) of the children. Half (25/50) of seropositive children were shedding in at
least one fluid. The proportion of seropositive children who shed in saliva was 100% (8/8) among the 4–12 month-olds,
64% (9/14) among 13–24 month-olds, and 40% (6/15) among 25–47 month-olds (P for trend = 0.003). Seropositive
mothers had a lower proportion of saliva shedding (21% [6/29]) than children (P < 0.001). Among children who were
shedding CMV, viral loads in saliva were significantly higher in younger children (P <0.001); on average, the saliva viral
load of infants (i.e., <12 months) was approximately 300 times that of two year-olds (i.e., 24–35 months). Median CMV
viral loads were similar in children’s saliva and urine but were 10–50 times higher (P < 0.001) than the median viral load
of the mothers’ saliva. However, very high viral loads (> one million copies/mL) were only found in children’s saliva
(31% of those shedding); children’s urine and mothers’ saliva specimens all had fewer than 100,000 copies/mL. Low IgG
avidity, a marker of primary infection, was associated with younger age (p = 0.03), higher viral loads in saliva (p = 0.02),
and lower antibody titers (p = 0.005).
Conclusions: Young CMV seropositive children, especially those less than one year-old may present high-risk CMV
exposures to pregnant women, especially via saliva, though further research is needed to see if this finding can be
generalized across racial or other demographic strata.
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Background
Congenital cytomegalovirus (CMV) is a leading viral cause
of childhood disability that remains underemphasized due
to challenges in diagnosis, prevention, and treatment
[1-5]. Many people are infected with CMV, yet most of
these infections are asymptomatic and therefore unlikely
to be diagnosed [6]. Thus, a pregnant woman may have
or acquire CMV infection and be unaware that she is
infected and at risk of passing the infection to her fetus
[7-10]. Furthermore, because most women are unaware
of CMV, and many pregnancies are unplanned (37% in
the United States [11]), opportunities for preventing
congenital CMV through behavioral change are often
missed [1,12-14].
Reducing risk for pregnant women requires a sound
understanding of CMV transmission routes and sources.
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CMV transmission appears to require direct contact with
infected body fluids. Seroconversion data point to young
children as an important source of infection for pregnant
women. In a comprehensive literature review, annual
seroconversion rates were much higher among child care
workers (8.5%) and parents with a child known to be
shedding CMV (24%) than among the general population
of pregnant women, healthcare workers, or parents with a
child known not to be shedding CMV (all with annual
seroconversion rates of ~2%) [15]. CMV infection can also
result from intimate contact between adults [16,17].
A better understanding of the relative importance of
children versus adults as sources of CMV infection might
lead to improved prevention messages for pregnant
women. Their risk of CMV infection is influenced by the
different ways in which they interact with children and
adults, but other factors may also be important. Although
young children are more prone to transfer body fluids to
others and into their surrounding environment, adults
also exchange body fluids with one another, perhaps less
indiscriminately, but with some frequency nonetheless.
Thus, it seems likely that infection risk may also be
influenced by viral or immunological factors, or by recency
of infection in the source (i.e., primary vs. non-primary
infection). Although some of these factors, such as preva-
lence of IgG antibody positivity or viral shedding, have
been explored thoroughly in children and adults, other
factors, such as IgG titers, IgG avidity, viral loads, recency
of infection, or specimen type (e.g., saliva vs. urine),
remain understudied. In addition, most studies of these
other factors [18-32] have not compared children and
adults or have been done in congenitally infected children
rather than in postnatally infected healthy children—the
latter being a more important infection source because
they greatly outnumber children with congenital infection.
To better understand factors that may influence CMV
transmission risk for pregnant women, we carried out a
descriptive epidemiology study of viral and immunological
factors in healthy children and compared them to factors
in adults (i.e., their mothers). In this way we hoped to
inform possible behavioral measures for preventing
maternal CMV infection or reinfection during pregnancy.
Methods
Study population
Over the course of approximately six months we enrolled
a convenience sample of children without chronic medical
conditions aged 0–47 months from the Atlanta, GA
metropolitan area for participation in this cross-sectional
study. None of the children had a diagnosis of congenital
CMV infection. Aside from age, the only other inclusion
requirement was that the child be using diapers. We used
a variety of recruitment methods including posted flyers,
e-mail list announcements, word-of-mouth, and on-site
recruitment in outpatient pediatric clinics. Subsequently,
we enrolled the mothers (N = 32) of those children who
tested CMV-seropositive and were selected for longitudinal
follow-up (Cannon et al., companion paper). The study was
approved by the Institutional Review Board (IRB) at the
U.S. Centers for Disease Control and Prevention (CDC).
Informed consent for each participant, signed by the
mother, was obtained during the enrollment process.
We administered a survey at the time of enrollment to
capture demographic and socioeconomic data such as sex,
age, race/ethnicity, day care attendance, household income,
insurance status, and mother’s educational attainment and
knowledge of CMV.
Specimen collection & testing
Children were tested for CMV IgG antibody in serum (i.e.,
CMV seropositivity) and CMV DNA in saliva and urine
(CMV shedding). Seropositive children were enrolled in a
12-week longitudinal follow-up study described elsewhere
(Cannon et al., companion paper). The mothers of CMV-
seropositive children were typically enrolled 2–4 weeks
after their child’s visit, and were tested for CMV IgG
antibody in serum and CMV DNA in saliva.
Blood specimens for antibody testing were taken via
finger stick (from mothers and older children) or heel
stick (from younger children). Blood was collected on a
dried blood spot (DBS) card which was allowed to dry.
DBS cards were delivered at room temperature to the
laboratory within 24 hours of collection and were stored
at −20°C pending laboratory testing. Serum was eluted
from the DBS as described [33] and tested using a stand-
ard CMV ELISA assay (Sera Quest®, Doral, Florida).
CMV IgG titration was done on blood specimens (when
enough remained) by performing two-fold dilutions and
testing by ELISA. Sufficient specimen remained to obtain
antibody titer results for 36 of 50 seropositive children
and 28 of 29 seropositive mothers.
CMV IgG avidity testing was performed on blood (when
enough remained) using standard Euroimmune® ELISA
kits (Luebeck, Germany) to identify recent infection. Suffi-
cient specimen remained to obtain antibody avidity results
for 40 of 50 seropositive children and 29 of 29 seropositive
mothers.
Saliva specimens from children were collected using
sterile oral swabs. Each swab was placed in the child’s
mouth for at least 20 seconds to ensure adequate absorp-
tion of saliva, and was then inserted into a collection tube.
Mothers’ saliva was collected by having study subjects
expectorate directly into sterile tubes. All specimens were
kept refrigerated during transport to the laboratory within
24 hours, where they were stored at −80°C pending labora-
tory testing.
Viral DNA was extracted from each swab through a
quick extract method to detect CMV DNA in saliva.
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After thawing, 300 μl of lysis/elution buffer were added
to each collection tube, which was then incubated and
mixed at 56°C for one hour and then at 100°C for two
minutes with agitation. The tube was then rapidly cooled
on ice for 5–10 minutes, after which it was centrifuged
for 1–2 minutes. The swab was removed and the specimen
was tested by CMV real-time PCR, targeting the glyco-
protein B gene [23].
Children’s urine was collected using a diaper insert.
Whatman® 903 filter paper (1″ × 4″) was inserted into
the inner panel of the diaper prior to placement on the
child. After urination, the insert was removed from the
diaper and allowed to air dry. The insert was transported
to the laboratory within 24 hours where it was stored
at −80°C pending laboratory testing.
Viral DNA was extracted from the filter paper via the
thermal shock method [34] to detect CMV DNA in
urine, with modifications as described by Kharrazi et al.
[33]. Taqman-based PCR was then performed that
targeted the CMV glycoprotein B gene [23].
The limits of PCR detection were estimated to be
1,600 copies/mL for saliva and 16,000 copies/mL for
urine. These limits are considerably higher than our
detection limit for sterile specimens (e.g., blood) collected
in clinical settings, which is 70 copies/mL. Two factors led
to these higher limits of detection: 1) To avoid false-
positives, the PCR assay cutoff was raised five-fold from
one copy per reaction (70 copies/ml) to five copies per
reaction (350 copies/ml) because saliva is not sterile and
urine was collected in an unsterile manner, and unsterile
specimens are more susceptible to trace amounts of
contamination from the environment; 2) The methods
of specimen collection (i.e., swabs and filter paper) were
necessary to enable in-home collection by mothers, but
they resulted in reduced sample volume which raised
the limit of detection approximately five-fold for saliva
in swabs and 50-fold for urine in filter paper.
Notably, urine dried on filter paper was usually colorless.
To confirm the presence of urine we tested for urea, follow-
ing the manufacturer’s instructions (Bioassay Systems®,
Hayward, CA), in a sample immediately adjacent to the
sample used for PCR. During recruitment, we were unable
to collect a urine specimen from seven of the children,
and an additional three urine specimens did not have
detectable urea on the filter paper and were thus excluded
from analysis. Consequently, urine results were available
for only 151 children.
Statistical analysis
Statistical analyses were done using SAS version 9.3
(Cary, NC). We calculated P-values for proportions by
using the Chi-Square or Fisher’s exact tests, as appropriate.
When comparing viral loads or antibody titers, we used the
Wilcoxon Rank-Sum test. To evaluate associations with
age, we performed linear regressions on log10 transformed
viral loads and on loge transformed antibody titers.
Results
We screened 161 children during the study (Table 1).
The children were different from the general population
of U.S. children in important ways, including that their
Table 1 Characteristics of children and mothers
Variable Result Comparable
U.S. averages
Sex of child (US population <5yrs
in 2010) [35]
Female 45% (72/161) 48.9%
Male 55% (89/161) 51.1%
Age of children
0–12 months 37% (60/161) NA
13–24 months 35% (57/161) NA
25–47 months 27% (44/161) NA




Non-Hispanic White 69% (111/160) 79.6%
Asian/Asian American 18% (29/160) 4.6%
Black/African American 8% (13/160) 12.9%
Other 4% (7/160) 2.9%
Ethnicity [36]
Hispanic 4% (7/161) 15.8%




Professional degree 18% (29/161) 10.2%
Master’s degree 22% (36/161)
Bachelor’s degree 35% (57/161) 19.4%
Some college 20% (32/161) 27.3% (includes
associate degrees)
High school/GED 1% (2/161) 30.7%
Less than high school 3% (5/161) 12.4%
Median household income $75,000-$100,000 $49,777 [38]
Insurance coverage [39]
Employer 76% (123/161) 55.8%
Self-insured 6% (10/161) 8.2%
Public 4% (6/161) 15.7% (Medicaid
stats only)
Don’t know/not covered 14% (22/161) 16.7% (uninsured)
Child ever attended day care 39% (63/161) 32.9% (non-relative
care) [40]
CMV seropositive- children 31% (50/161) 37.5% [41]
CMV seropositive - mothers 91% (29/32) 56.7% [41]
*Data missing for one child.
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parents had above average educational attainment and
household income and were more likely to have health
insurance through their employers. Nearly one third
(31%) of the children were CMV-seropositive (Table 1,
Figure 1). Of these, half were shedding CMV in saliva
and/or urine (Figure 1). Of the 111 seronegative children,
three were shedding CMV in saliva or urine (Figure 1).
We also screened 32 mothers of CMV-seropositive chil-
dren, of whom 29 (91%) were CMV-seropositive (Table 1).
The age range of their children was similar to the age
range of all the children in the study (data not shown).
CMV seroprevalence was higher among older children,
with the exception that 0–3 month-olds had an elevated
seroprevalence (Figure 2), presumably the result of some
having antibodies transferred passively from their mothers.
Among the 13 seropositive children aged 0–3 months, only
five had evidence of infection—either viral shedding or low
avidity antibodies. Among seropositive children aged 4–12
months, all were shedding CMV and therefore were likely
to have had their own infection, rather than maternal
antibodies only.
Among children, prevalence of shedding did not change
significantly with age in either saliva (P for trend =0.70)
or urine (P for trend =0.63). However, the proportion
of seropositive children who shed in saliva decreased
(Figure 2) from 100% (8/8) among the 4–12 month-
olds, to 64% (9/14) among 13–24 month-olds, to 40%
(6/15) among 25–47 month-olds (P for trend = 0.003).
Seropositive mothers had an even lower proportion of
saliva shedding (21% [6/29]). Of the three seronegative
mothers, two had children who were shedding in saliva
and/or urine, and therefore would have elevated risk of
acquiring CMV from their children. None of the three
seronegative mothers seroconverted during the 12-week
longitudinal follow-up study (Cannon et al., companion
paper).
Although shedding prevalence was higher (Figure 1) in
children’s saliva (16% [26/161]) than in urine (8% [12/
151]), a direct comparison is inappropriate because the
limit of PCR detection for saliva (1,600 copies/mL) was
lower than for urine (16,000 copies/mL). When using the
less sensitive limit for both fluids (i.e., 16,000 copies/mL),
the difference between shedding prevalences (Figure 3)
was small (11% vs. 8%, P =0.34).
Among children who were shedding CMV, viral loads
were significantly lower (Figure 3) at older ages for saliva
(P <0.001) but not for urine (P = 0.22). On average, the
saliva viral load of infants (i.e., <12 months) was approxi-
mately 300 times that of 2 year-olds (i.e., 24–35 months)
(Figure 3). Median CMV viral loads were similar in
children’s saliva and urine (Figure 4A, Table 2), but
were 10–50 times higher (P < 0.001) than the median
viral load of the mothers’ saliva (Figure 4A, Table 2). Of
note, viral loads at the high end of the distributions
were even more disparate—for example, more than
25% of the children’s saliva viral loads were greater than
Figure 1 Number, antibody status, and CMV shedding status of children enrolled in the study. Red outlines represent children with CMV
IgG antibody and blue outlines represent children without CMV IgG antibody. Yellow shading represents children shedding CMV in urine only,
blue shading represents children shedding in saliva only, and green shading represents children shedding in both urine and saliva. CMV testing
was also done in a subset of mothers of children who were CMV antibody positive.
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one million copies/mL, while all of the children’s urine
viral loads and mothers’ saliva viral loads were less than
100,000 copies/mL (Figure 4A). Among children shedders,
low antibody avidity was associated with higher viral loads
in saliva (Figure 4B, Table 2), but day care attendance was
not associated with higher viral loads in saliva or urine
(Figure 4C, Table 2).
Mothers’ antibody titers were higher than those of
children (Table 2, Figure 5B), and among children anti-
body titers increased with age (Figure 5A). Children
0–12 months were more likely to have low avidity anti-
bodies (36%, 6/17) than were older children (4% [1/23])
(P = 0.03). Antibody titers were not associated with
shedding in one or more specimen types (Figure 6A, all
pairwise P values >0.20), but were associated with high
or intermediate antibody avidity (Figure 6B, Table 2,
P = 0.005). All three mothers with low antibody avidity



























































Figure 2 Prevalences of CMV IgG antibody and CMV shedding in saliva among children as a function of age in months. Prevalences of
CMV IgG antibody and CMV shedding in saliva are also shown for the mothers who were screened. Red shading represents antibody results and
blue shading represents saliva results. Panel A shows data from children ages 0-3 months; Panel B shows data from children ages 4-47 months;
Panel C shows data from mothers. Antibody prevalences of mothers and children are not directly comparable because the children came from an
unselected population whereas the mothers were selected for testing only if their children were CMV-seropositive, and therefore the seroprevalence
among mothers was higher than would be expected in a general population.
A B
Figure 3 CMV viral loads per mL as a function of children’s ages in months. Panel A shows results for saliva viral loads and panel B shows
results for urine viral loads. Circles are only plotted for children who were shedding; negative results (i.e., viral loads below the limit of detection)
are not plotted. Yellow circles represent children shedding CMV in urine only, blue circles represent children shedding in saliva only, and green
circles represent children shedding in both urine and saliva. The regression line in Panel A is log10 (CMV viral load) =7.1 – 0.108 (age in months),
with r2 = 0.46 and P < 0.001; the regression line in Panel B is log10 (CMV viral load) =5.2 – 0.014 (age in months), with r
2 = 0.14 and P = 0.22.
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high viral loads in saliva (>750,000 copies/mL), but only
one of these mothers was shedding herself.
Day care attendance was associated with a three-fold
higher prevalence of viral shedding (Table 2, P <0.001)
and with an 11% higher seroprevalence (38% vs. 27%),
though the latter association did not achieve conventional
levels of statistical significance (Table 2, P = 0.06). In con-
trast, day care attendance was not a predictor of high
CMV viral loads in saliva or urine, low avidity antibodies,
or high antibody titers (Table 2).
Discussion
Our study of the descriptive epidemiology of CMV infec-
tion among children and mothers produced several new
findings that have implications for prevention of CMV
infection among women of reproductive age: 1) more than
half of CMV-seropositive healthy young children shed
CMV DNA in saliva and/or urine, a much higher shed-
ding rate than that of seropositive healthy adults; 2)
among seropositive children, the prevalence of shedding
and the magnitude of CMV viral loads tended to be
greater among younger children; 3) CMV viral loads were
typically higher in children’s saliva and urine than in
mothers’ saliva; 4) the highest viral loads (> one million
copies/mL) were only found in children’s saliva; 5) low
CMV IgG avidity was associated with younger age, CMV
shedding, and low CMV IgG titers; and 6) high CMV IgG
titers were associated with older age. We will discuss each
of these new findings and their implications in turn.
Although adults have higher CMV seroprevalence than
children [41], we found that seropositive children are
much more likely to shed CMV. In our study, more than
half of the CMV-seropositive children were shedding
compared to one-fifth of the CMV-seropositive mothers.
Furthermore, after excluding the children aged 0–3
months, presumably all of whom were likely to have had
passively acquired maternal antibodies, we found that
younger seropositive children were more likely to shed
CMV than older seropositive children. The higher pro-
portion of shedding in seropositive children, especially
younger children, may help explain why they are an
important source of CMV infection [15]. It also suggests
that adults may have better immune control of CMV,
that duration of shedding is longer for primary infections
(since the children are more likely to have had recent
primary infections), or that children are more likely to
be exposed to reinfections.
The finding of a high proportion of shedding among
seropositive children is new; although dozens of studies
have measured CMV shedding among children, we could
only identify eight previous studies that measured both
viral shedding and antibody among healthy children (i.e.,
children without congenital CMV) [20,22,42-47]. However,
most of these studies either did not report the shedding
proportion among the seropositives or did not look at both
laboratory tests in the same children. Only one of these
studies [47] reported an unbiased proportion of shedding
among seropositive children—33% (7/21)—but most of the
children were older—in fact, only five seropositive children
were under the age of five, which may, in light of our
finding of less shedding among older children, have led
to a lower shedding proportion in that study. Importantly,
our prevalence of shedding in seropositive adults is likely
to be an overestimate because, unlike the children in the
study, the mothers were selected for testing because they
already had a risk factor, i.e. a CMV seropositive child.
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Figure 4 CMV viral loads per mL stratified by three different variables. Panel A shows viral loads stratified by specimen type (saliva vs.
urine) and source (child vs. mother). Panel B shows viral loads for children only stratified by whether the child had high or intermediate versus
low CMV IgG antibody avidity. Panel C shows viral loads stratified by day care attendance. Circles are only plotted for children who were
shedding; negative results (i.e., viral loads below the limit of detection) are not plotted. Blue circles represent saliva results and yellow circles
represent urine results.
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Mean Median Mean Median
Group
Children 17% (28/161) 1.6 × 107 1.6 × 105 1.1 × 105 9.6 × 104 0.37d 31% (50/161) 18% (7/40) 224
Mothers 19% (6/32) 0.83 6.1 × 103 4.9 × 103 <0.001 − − <0.001e 91% (29/32) f 10% (3/29) 0.50 464 0.002
CMV IgG avidity (all)
Low 60% (6/10) 1.6 × 106 2.5 × 106 − − − − 136
High or intermediate 39% (23/59) 0.30 4.4 × 104 1.2 × 104 0.02 − − NA − NA − NA 353 0.005
CMV shedders
(children only)
No − − − − − 19% (25/133) 12% (2/17) 321
Yes − NA − − NA − − NA 89% (25/28) <0.001 23% (5/23) 0.68 290 0.68
Day care attendance
(children only)
Never 9% (9/98) 5.9 × 106 3.7 × 105 1.4 × 105 1.1 × 105 27% (26/98) 21% (4/19) 192
Ever 30% (19/64) <0.001 2.1 × 107 1.6 × 105 0.63 8.9 × 104 6.5 × 104 0.38 38% (24/63) 0.06 14% (3/21) 0.69 258 0.35
aWilcoxon Rank-Sum test comparing log10 viral loads in saliva.
bWilcoxon Rank-Sum test comparing log10 viral loads in urine.
cWilcoxon Rank-Sum test comparing geometric mean titers (GMT).
dComparison is between children’s saliva and urine.
eComparison is between children’s urine and mothers’ saliva.
fAntibody prevalences between mothers and children were not directly comparable because the children came from an unselected population whereas the mothers were selected for testing only if their children were
CMV-seropositive, and therefore the seroprevalence among mothers was higher than would be expected in a general population.
Dashes are inserted where a comparison does not make sense or is redundant, or where data were insufficient.




















This may explain why our shedding proportion (21%) was
somewhat higher than that of previous studies of seroposi-
tive women, where the summary proportion of shedding
in oral secretions was 13% (74/556), though the difference
was not statistically significant [24,25,48-51].
In contrast to some previous findings, we found that
CMV shedding in children was similar (using equivalent
limits of PCR detection) for saliva (11%) and urine (8%).
Previous studies that measured both urine and saliva
shedding in healthy children found CMV more frequently
in urine, with the prevalence difference ranging from
2%–20% [24]. However, one important difference between
our study and these previous studies was that we mea-
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Figure 5 CMV IgG antibody titers among children and mothers. Panel A shows antibody titers as a function of age in months, including a
regression line plotted to show the linear relationship between age in months and loge viral loads. Panel B shows antibody titers among mothers,
who had a median age of 34 years. Overall geometric mean antibody titers for children and for mothers are shown near the bottom of each panel.
Circles are only plotted for individuals who had CMV IgG antibodies; negative results (i.e., antibody titers of zero) are not plotted. Black circles represent


















Low avidity High or intermediate avidity
Avidity status
Geometric means: 321 252 400 136 353
A B
Figure 6 CMV IgG antibody titers as a function of CMV shedding status and CMV IgG antibody avidity status. Panel A shows antibody titers
for individuals not shedding CMV, shedding CMV in only one specimen (urine or saliva), or shedding CMV in both urine and saliva. Panel B shows
antibody titers for individuals with low avidity versus high or intermediate avidity. Geometric mean antibody titers for each category are shown near
the bottom of each panel. Circles are only plotted for individuals who had CMV IgG antibodies; negative results (i.e., antibody titers of zero) are not
plotted. Black circles represent mothers’ results and white circles represent children’s results. For easier viewing, some of the circles are slightly offset
from their true values; actual values for inverse antibody titers consisted only of the following: 50, 100, 200, 400, 800, 1600, and 3200.
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used viral culture, which might be partially responsible for
our slightly different findings.
We also found that CMV viral loads were significantly
higher in children’s saliva and urine than in mothers’ saliva,
suggesting that children may be an especially important
source of infection for pregnant women. Furthermore, the
very highest viral loads (> one million copies/mL) were
all in children’s saliva, suggesting that exposure to saliva
may pose an even greater risk for pregnant women than
exposure to urine. We were only able to identify one
previous study—from The Gambia—that compared viral
loads in children and mothers [22]. In that study viral
loads were similar in the saliva and urine of both groups.
However, we might not expect similar results since the
mothers and children in Atlanta may differ in important
ways, such as nutritional status or co-morbidities, from
the mothers and children in The Gambia [22]. Another
study, among children at day care centers in Iowa, found
slightly higher viral loads in saliva than in urine, but only
four children were assessed [19].
CMV viral loads were higher among younger children,
suggesting that they may be an especially important source
of infection for pregnant women. This finding has not been
shown previously, and might be explained in part by CMV-
infected younger children being more likely to have a
recent primary infection—since they have had fewer
months to be exposed to reinfections—and viral primary
infections tend to be associated with higher viral loads [52].
Among children, low CMV avidity was associated with
younger age, higher viral loads, and lower antibody titers,
which is consistent with the assumption that shedding in
younger children is more likely to be associated with a
primary CMV infection. In addition, the higher antibody
titers among older children, and the higher antibody titers
among mothers compared to children, are consistent with
anti-CMV immune boosting through repeated antigenic
exposures, whether due to reactivations or reinfections.
Our study had several limitations. First, our study chil-
dren were identified through a convenience sample rather
than a representative sample of the underlying population.
They included an overrepresentation of both non-Hispanic
Whites and Asians/Asian-Americans. Second, we screened
only 161 children. Nevertheless, our sample was relatively
large compared to previous studies that assessed CMV
shedding and viral load in multiple body fluids of healthy
young children. Third, we collected saliva and urine using
different materials (i.e., swabs vs. filter paper), and so we
could not directly compare shedding prevalences or median
viral loads unless we excluded the saliva results that fell
below the limit of PCR detection for urine. If we had been
able to collect liquid urine we might have found a higher
shedding prevalence in urine, but we may have also found
that the difference between median viral loads would have
become significantly higher for saliva (since some lower
viral load results might have been added for urine). Fourth,
we do not know whether any of the children in the study
were infected congenitally because none was tested before
three weeks of age. However, none of the children had a
clinical diagnosis of congenital CMV and all were generally
healthy. Fifth, we did not usually place the specimens in
viral cultures but instead used PCR to quantify CMV DNA;
thus, the presence of infectious virions was not demon-
strated in most cases. This approach would be expected
to overestimate the number of infectious particles in
specimens. For a small number of specimens we also
performed viral cultures and often found evidence for
infectious virions (unpublished data). Nevertheless, as
with other viruses that are typically detected using
PCR, such as HIV or HSV-2, the high levels of viral DNA
probably indicate the presence of infectious virions in
most cases. Last, because this was a cross-sectional study,
children were tested at only one time point. Because CMV
shedding can be sporadic, some of the CMV-seropositive
children who were not shedding at their study visit may
have been shedding previously or subsequently. Thus,
our estimate that 17% of children were shedders under-
estimates the prevalence of shedders over a longer time
interval (Cannon et al., companion paper).
It is likely that some of the children originally acquired
their CMV infections from their mothers via breast feed-
ing. We did not ask questions about breast feeding and
did not collect or test breast milk, so we cannot be sure
whether the saliva of any of the children in the study was
contaminated with CMV-infected breast milk. However,
such contamination is unlikely because the study procedure
mandated saliva collection no sooner than one hour after
breastfeeding, and the young children’s saliva viral loads
were much higher than the peak viral loads typically found
in breast milk [53,54].
Taken together, our findings can be used to inform
behavioral prevention messages. To decrease transmis-
sion of CMV, the American Academy of Pediatrics (AAP)
has advised hand hygiene when caring for children,
particularly after changing diapers [55]. Similarly, the
American College of Obstetricians and Gynecologists has
advised women with young children to use safe-handling
techniques after handling diapers or after exposure to
respiratory secretions [56]. In addition to this advice,
researchers who have conducted CMV behavioral inter-
ventions have also advised women to avoid kissing
young children on the mouth, to refrain from sharing
food, drink, and utensils, and to cleanse toys and other
objects that may be exposed to children’s body fluids
[1,12,14,57,58]. Our findings suggest that although hand-
washing to minimize urine exposures is important (e.g.,
after diaper changes), behaviors that reduce saliva expo-
sures may be even more important. Saliva appears to have
higher CMV viral loads and is more likely to get into the
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environment through drooling, eating, pacifier use, etc.
Urine, by contrast, is usually blocked by diapers. Further-
more, saliva has more opportunities to directly contact the
eyes, nose and mouth of a pregnant woman (kissing,
sharing food and drinks), whereas, urine contact is typically
less direct (diaper-to-hand-to-eye). Because women may
not recognize how frequently they come into contact with
children’s saliva, it may be important to emphasize behav-
iors that prevent saliva from directly contacting the mouth
or other mucous membranes (e.g., kissing on the mouth or
sharing food/drink and utensils).
Conclusions
Young CMV seropositive children, especially those less
than one year-old may present high-risk CMV exposures
to pregnant women, especially via saliva, though further
research is needed to see if this finding can be generalized
across racial or other demographic strata. Data on shed-
ding among young children will be critical for developing
and evaluating prevention messages and behavioral inter-
ventions in order to identify effective strategies to prevent
CMV transmission.
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